Dipeptidyl Peptidase-4 Inhibitor Induced Bullous Pemphigoid Complicated by Acquired Reactive Perforating Dermatosis

Actas Dermosifiliogr. 2022 Oct;113(9):914-915. doi: 10.1016/j.ad.2021.01.023. Epub 2022 May 27.

[Article in English, Spanish]

Authors

T Gambichler¹, B Espey¹, M Doerler¹, R Stranzenbach²

Affiliations

¹ Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
² Department of Dermatology, Ruhr-University Bochum, Bochum, Germany. Electronic address: rene.stranzenbach@rub.de.

PMID: 35636509
DOI: 10.1016/j.ad.2021.01.023

No abstract available

Publication types

Case Reports

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Dipeptidyl-Peptidase IV Inhibitors* / adverse effects
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
Humans
Non-Fibrillar Collagens
Pemphigoid, Bullous* / chemically induced
Skin Diseases*

Substances

Dipeptidyl-Peptidase IV Inhibitors
Non-Fibrillar Collagens
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases